Alloy Therapeutics

Raised $40M in a Series E round, announced 15 April 2026.

Total raised
$40M

Latest round Series ECountry United StatesSector Health

Round

$40MSeries E, 15 April 2026

Raised at about a $1B valuation to expand discovery services and AI data infrastructure.

Amount
$40M
Stage
Series E
Announced
15 April 2026
Lead
8VC
Other investors
JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Thiel Capital, Founders Fund
Use of funds
Raised at about a $1B valuation to expand discovery services and AI data infrastructure.
Checked
Announced by the company
Sources
Alloy Therapeutics announces $40M Series E at $1B valuation alloytx.com
Alloy Therapeutics announces $40M Series E at $1B valuation ventureburn.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Drug discovery platforms and services offered to biotech and pharma partners

Based in
Waltham, United States
Sector
Health
Website
alloytx.com ↗

Links

Website
alloytx.com ↗

Questions

How much has Alloy Therapeutics raised?

Alloy Therapeutics raised $40M in a Series E round, announced on 15 April 2026.

Who invested in Alloy Therapeutics?

8VC led. Investors include 8VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Thiel Capital and Founders Fund.